Pfizer regains footing - Analysis - 16-08-2018

Pfizer's stock rose anew in the intraday levels, amid positive support from the 50-day SMA, amid the dominance of the main upward short-term trend, scoring a profit of 1.11% in the last session, or 0.45 points, while the Relative Strength Index reached extremely oversold levels compared to the stock's movements. 

Therefore we expect more gains for the stock, especially if the resistance of 41.12 was breached, targeting the next one at 43.29.